Sarepta Therapeutics Inc (SRPT)
109.05
-3.43
(-3.05%)
USD |
NASDAQ |
Nov 14, 16:00
109.08
+0.03
(+0.03%)
After-Hours: 20:00
Sarepta Therapeutics Gross Profit (Annual): 1.093B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.093B |
| December 31, 2022 | 793.02M |
| December 31, 2021 | 604.84M |
| December 31, 2020 | 476.72M |
| December 31, 2019 | 324.25M |
| December 31, 2018 | 266.84M |
| December 31, 2017 | 147.23M |
| December 31, 2016 | 5.32M |
| December 31, 2015 | 1.253M |
| December 31, 2014 | 9.757M |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 |
| Date | Value |
|---|---|
| December 31, 2009 | 17.58M |
| December 31, 2008 | 21.26M |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | 1.714M |
| December 31, 1999 | 0.40M |
| December 31, 1998 | 0.30M |
| December 31, 1997 | 0.60M |
| December 31, 1996 | 0.60M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
324.25M
Minimum
2019
1.093B
Maximum
2023
658.36M
Average
604.84M
Median
2021
Gross Profit (Annual) Benchmarks
| Catalyst Pharmaceuticals Inc | 346.24M |
| Vertex Pharmaceuticals Inc | 8.607B |
| Alnylam Pharmaceuticals Inc | 1.518B |
| Biomarin Pharmaceutical Inc | 1.904B |
| Cytokinetics Inc | -322.59M |